Coya Therapeutics
COYA
19 hedge funds and large institutions have $19.8M invested in Coya Therapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 19 → 19 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
1.49% less ownership
Funds ownership: 22.96% → 21.47% (-1.5%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
40% less capital invested
Capital invested by funds: $33.1M → $19.8M (-$13.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$134K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$95K |
| 3 |
BlackRock
New York
|
+$85K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$81.1K |
| 5 |
GC
Gilbert & Cook
West Des Moines,
Iowa
|
+$80.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.09M |
| 2 |
Jane Street
New York
|
-$199K |
| 3 |
State Street
Boston,
Massachusetts
|
-$25.7K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$12.2K |
COYA Hedge Fund Activity: Q2 2024 in Review
19 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q2 2024, worth a combined $19.8M — down 40% from $33.1M a quarter earlier.
Fund positioning in COYA was balanced in Q2 2024: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 6 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $134K. The largest seller was Raymond James & Associates, exiting entirely with an estimated $1.09M sold.
- 19 institutional investors held Coya Therapeutics (COYA) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $19.8M of Coya Therapeutics stock for Q2 2024, down 40% quarter-over-quarter.
- 4 funds opened new Coya Therapeutics positions in Q2 2024 and 4 closed out, a net change of 0 holders.
- The largest Coya Therapeutics buyer in Q2 2024 was Renaissance Technologies, an estimated $134K added.
- The largest Coya Therapeutics seller in Q2 2024 was Raymond James & Associates, an estimated $1.09M sold.
Based on aggregated 13F filings for Q2 2024.